Mixed clinical findings remain visible
Sections 7.1–7.2 and Tables 1–2 report significant, nonsignificant, and comparator-equivalent blood-pressure findings rather than presenting only favourable studies.
↳ Sections 7.1–7.2; Tables 1–2
Abstract
Hypertension (HTN) is one of the greatest public health challenges of the 21st century. Its prevalence has reached alarming levels in recent decades. The search for effective prevention and treatment strategies includes lifestyle choices, such as dietary interventions. Although not applicable to everyone, particularly interesting in this context is the ketogenic diet (KD), known to clinicians and also applied in epilepsy treatment for over a century. Its possible beneficial effects are increasingly often reported in many other conditions, including HTN. The aim of the present study is to analyse the effect of a KD on blood pressure, and the mechanisms that may modulate that effect. Based on the available literature, key potential pathways of the influence of a KD on blood pressure regulation have been identified: (1) reduced body weight; (2) reduced visceral adipose tissue; (3) improved insulin sensitivity; (4) improved water and electrolyte balance; and (5) anti-inflammatory effect. Meta-analyses and randomised controlled trials consistently indicate that ketogenic dietary interventions are associated with reductions in blood pressure, although the magnitude of the effect varies considerably depending on the ketogenic diet model, study population, and comparator. In light of these observations, it has been found that in patients undergoing pharmacological treatment, it may be necessary to appropriately reduce antihypertensive medication dosage in advance. To maximise the hypotensive effect of a KD, the need to ensure an adequate supply of potassium, magnesium, and high-quality products, as well as proper hydration has been emphasised. Further studies are needed, with the effect of a KD on systolic and diastolic blood pressure as the primary endpoint, taking into account the role of the qualitative composition of the diet in the observed effects.
Key Claims
Primary findingUnsupported
Meta-analyses and randomised controlled trials consistently indicate that ketogenic dietary interventions are associated with reductions in blood pressure
the review’s own meta-analyses and trials include null and comparator-equivalent blood-pressure findings
Abstract
SecondaryTentative
it may be necessary to appropriately reduce antihypertensive medication dosage in advance
the recommendation is extrapolated from physiological mechanisms without a direct medication-titration evidence base
Abstract; Section 8
SecondaryTentative
the antihypertensive effects of the ketogenic diet are most likely the result of multiple complementary and interacting physiological mechanisms
the narrative synthesis cannot directly identify the relative or combined causal contribution of the proposed mechanisms
Section 6.5.2
Derived from the full evaluation — not a separate score.
Strengths · Limitations
Strengths
Mechanisms are organised into one framework
Section 6 links weight loss, visceral fat, insulin sensitivity, fluid and electrolyte balance, and inflammation, then describes their interactions rather than treating them as independent pathways.
↳ Sections 6.1–6.5; Figure 3
Important boundary conditions are acknowledged
The review distinguishes normocaloric, low-quality, and very-low-calorie ketogenic models and states that evidence for high-quality normocaloric diets in hypertensive patients remains limited.
↳ Section 2
Limitations
Headline overstates evidentiary consistency
The Abstract says meta-analyses and trials consistently show blood-pressure reductions, while Section 7.1 and Tables 1–2 include nonsignificant and comparator-equivalent findings.
↳ Abstract; Section 7.1; Tables 1–2
Review selection is not reproducible
Section 5 lists databases and search terms but omits eligibility criteria, search dates, screening counts, and a quality-appraisal method for the heterogeneous included evidence.
↳ Section 5
Clinical medication advice lacks direct support
The suggestion to reduce antihypertensive medication in advance is extrapolated from diuresis and electrolyte mechanisms rather than a reviewed medication-titration evidence base.
↳ Abstract; Sections 6.4 and 8
Nabu Commentary
The review’s strongest feature is its structured synthesis of five mechanisms and its inclusion of mixed meta-analytic and trial results in Tables 1–2. Its contribution is limited because the diet-quality framework introduced in Section 2 is not used to classify or explain the clinical heterogeneity systematically. Section 5 provides only a broad narrative search description, without reproducible selection or quality-appraisal procedures. Most importantly, the Abstract’s claim of consistent blood-pressure reduction conflicts with Section 7.1, which expressly reports nonsignificant findings and difficulty separating ketosis from weight loss and calorie restriction.
Author Note / Field Feedback
Nabu’s assessment, alongside the field’s view.
Are you an author of this paper?
Dimension breakdown
Study Quality
Limited2.8
Contribution
2.4
The review integrates five physiological pathways with clinical evidence and adds a potentially useful distinction among ketogenic-diet models. Its principal conclusion overstates consistency, and the proposed diet-quality moderator is not applied systematically to the studies in Tables 1–2.
Abstract; Sections 2 and 6; Tables 1–2
“Meta-analyses and randomised controlled trials consistently indicate”
Methodological Rigour
3.0
The mechanistic sections and evidence tables provide a traceable narrative that includes favourable, null, and comparator-equivalent findings. Section 5 does not report eligibility criteria, screening counts, search dates, or a quality-appraisal process, limiting reproducibility and evidence weighting.
Section 5; Sections 6–7; Tables 1–2
“deliberately selected for the heterogeneity of the sources included”
Reporting
3.2
The progression from diet definitions through mechanisms, trials, and practical considerations is easy to follow. The Abstract nevertheless gives a materially more uniform account of the evidence than Section 7 and the tables support.
Abstract; Sections 2, 6 and 7; Tables 1–2
“consistently indicate that ketogenic dietary interventions are associated with reductions in blood pressure”
Positioning
2.8
The review engages DASH, lipid trade-offs, null studies, population heterogeneity, and the difficulty of separating ketosis from weight loss. Its Abstract then characterises the evidence as consistent despite Section 7.1 expressly stating that not all meta-analyses confirm a significant effect.
Sections 2, 4 and 7.1; Abstract
“not all meta-analyses confirm the KD’s significant effect on blood pressure”
Reliability
Caveats4 of 4 checks
Internal CoherenceNoted
The headline description of consistently reduced blood pressure is stronger than the mixed evidence presented in the review body. The numerical summaries and tables are otherwise internally consistent.
Research ConductClean
This narrative review presents no original participant data requiring ethics approval, and no conduct-related inconsistency was identified in the supplied text.
Flags: 0 declared / 5 total
Reference IntegrityNoted
104 of 113 checkable references verified
117 references in manuscript 3 are books, websites or datasets — counted, but not index-checkable 1 could not be checked — not the same as no match found the reference list may be incompletely parsed; counts are indicative
Post-Publication RecordClean
No retraction notice found in Retraction Watch.
Last checked: 25 Aug 2026
Sources: Retraction Watch ✓
Impact Potential
Low2.9
Relevance
3.2
Hypertension is a high-burden clinical problem, and clinicians supervising dietary and antihypertensive treatment are an identifiable audience. The paper does not specify a guideline, service pathway, or defined implementation protocol.
Introduction; Abstract; Section 8
“in patients undergoing pharmacological treatment”
Readiness
2.6
The evidence base includes randomised trials conducted in clinical populations, placing the topic beyond a purely mechanistic stage. The review does not supply validated medication-adjustment procedures or a standardised ketogenic intervention ready for routine deployment.
Sections 7.1–7.2; Abstract
“Further studies are needed”
Generalizability
2.5
The review discusses several populations, comparators, calorie levels, and ketogenic models, making boundary conditions visible. Transfer to routine hypertension care remains uncertain because evidence for high-quality normocaloric ketogenic diets in hypertensive patients is limited.
Section 2; Sections 7.1–7.2; Tables 1–2
“evidence specifically addressing high-quality normocaloric ketogenic diets in patients with hypertension remains limited”
Trajectory
3.5
The review identifies a concrete next step: trials with systolic and diastolic blood pressure as primary endpoints that account for diet quality. This provides a usable research agenda even though the current synthesis does not resolve the central heterogeneity.
Abstract; Section 2; Section 7.1
“with the effect of a KD on systolic and diastolic blood pressure as the primary endpoint”
AI-generated, human-governed. Something look off? Contact us to request a review.